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To improve therapy of cardiovascular system
diseases, a number of medicinal substances are used
in the form of complex drugs, as in the case of
hydrochlorothiazide and metoprolol (1).
Both constituents of this drug hare similar
physicochemical properties, thus arising difficulty
in their identification and quantitative determina-
tion. This is why separating methods with the use of
chromatography and electrophoresis predominate in
analytical reports.
To determine hydrochlorothiazide in medicinal
products (beside lisinopril, amilorid, methyldopa
and losartan) chromatographic methods were used
(2ñ4). Angiotensin convertase inhibitors were deter-
mined along with hydrochlorothiazide by capillary
electrophoresis method (5). Good results of quanti-
tative analysis for this substance in complex drugs
beside enalapril, amilorid, atenolol, propranolol and
triamteren were obtained with UV spectrophotome-
try (6ñ10). 
Metoprolol as well as hydrochlorothiazide in
complex drugs were determined with chromato-
graphic methods (11ñ13).
In this paper a new spectrophotometric method
for simultaneous determination of hydrochlorothia-
zide and metoprolol is presented. Due to interfer-
ences in zeroñorder spectra and significant differ-
ences in concentration of both constituents in the
preparation, derivative spectrophotometry was used
for quantitative analysis by using a slight inflexion
at λ~282 nm in the zeroñorder spectrum. An attempt
was made to find suitable derivatives and wave-
length for quantitative analysis at which both con-
stituents show no interference. 
As no similar analyses were found in available
literature it seems justifiable to develop a simple,
quick and easily available spectrophotometric
method for drug quality control purposes. 
EXPERIMENTAL
Materials
MET ñ metoprolol tartrate ñ (Astra H‰ssle,
Germany) 
HYD ñ hydrochlorothiazide ñ (Merck, Germany)
Metoprolol-Ratiopharm ñ (Rathiopharm, 
comp tablets Germany)
Methanol ñ (Merck, Germany)
Apparatus
(a) Spectrophotometer UVñVis Cary 100 (Varian),
10 mm quartz cells 
(b) Computer ñ PC Pentium MMX, 16 MB RAM,
Hewlettñ Packard LaserJet 6L printer and soft-
ware (Microsoft Office 97, Statistica 5.1 edition
97).
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Abstract:A procedure for simultaneous determination of metoprolol and hydrochlorothiazide in tablets by
employing derivative spectrophotometry, ìzero-crossingî method was developed. The third order derivative
absorption spectra at λ~281 nm were used for metoprolol and the first order derivative spectra at λ~282 nm
were used for hydrochlorothiazide. No interferences were found between both determined constituents and
those of matrix. A good accuracy and precision of simultaneous determination of metoprolol and
hydrochlorothiazide were confirmed by statistical analysis. The recovery of individual constituents under estab-
lished conditions is very high and ranges from 98.79% to 99.39%. Linearity is maintained within a wide con-
centration range from 100.0 µg.mL-1 to 300.0 µg.mL-1 and from 12.5 µg.mL-1 to 37.5 µg.mL-1 for metoprolol
and hydrochlorothiazide, respectively. The detection limit is 5.0 µg.mL-1 for metoprolol and 1.5 µg.mL-1 for
hydrochlorothiazide. The corresponding quantitation limits are 15.0 µg.mL-1 for metoprolol and 4.5 µg.mL-1 for
hydrochlorothiazide. 
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Metoprolol and hydrochlorothiazide standard
solutions
Standard solutions were prepared in methanol:
metoprolol at concentrations from 100.0 µg.mL-1 to
300.0 µg.mL-1 by dilution of basic solution of 2.0
mg.mL-1,
hydrochlorotiazide at concentrations from 12.5
µg.mL-1 to 37.5 µg.mL-1 by dilution of basic solution
of 0.25 mg.mL-1.
Sample solutions
From powdered mass of 20 drug tablets 0.35 g
was weighed and 5.0 mL of methanol was added.
The mixture was shaken for 15 minutes. The
obtained suspension was filtered and 1.0 mL of clear
solution was taken and filled up to 100 mL with
methanol.
RESULTS AND DISCUSSION
Establishing the measurement conditions
There were well developed zero-order absorp-
tion spectra recorded for standard solutions (Fig. 1).
There are two absorbance maxima for hydrochloro-
thiazide, higher one at λ~271 nm and lower at λ~317
nm. For metoprolol there is a maximum at λ~276 nm
and characteristic inflexion at λ~282 nm (Fig.1).
The solution absorption spectrum recorded for a
mixture in which the concentrations of both constituents
are comparable to those of the preparation under investi-
gation, shows spectral interferences originated from
individual constituents, thus making simultaneous deter-
mination impossible. By using the characteristic inflex-
ion at λ~282 nm favourable conditions were established
for derivative spectrophotometry (14) (Fig. 2).
Figure 2. Third order uv derivative spectra for hydrochlorothiazide (A) and metoprolol (B) (c1= 100.0 µg.mL-1, c2=150.0 µg.mL-1, c3= 200.0
µg.mL-1, c4= 250.0 µg.mL-1, c5= 300.0 µg.mL-1).
Figure 1. Zero order uv spectra for preparation (A) hydrochlorothiazide (B) and metoprolol (C).
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There are well developed third order derivative
absorption spectra (Figure 2) showing clearly indicat-
ed extremes. At wavelength λ~281 nm chosen for
determining metoprolol, the value of third derivative
absorption spectrum originated from hydrochloroth-
iazide is zero. No hydrochlorothiazide interferences
are observed even at different concentrations (Fig. 3). 
To determine hydrochlorothiazide the first
order derivative spectra were used by making meas-
urements at λ~282 nm (Fig. 4), at which D1= 0 for
metoprolol. Any change in metoprolol concentration
has no effect on the measurements of derivative D1,
chosen for quantitative determination of hydro-
chlorothiazide (Fig. 5).
Figure 4. First order derivative uv spectra for metoprolol (A) and hydrochlorothiazide (concentrations as on Fig.3) (B).
Figure 3. Third order derivative uv spectra for hydrochlorothiazide (c1= 12.5 µg.mL-1, c2=18.8 µg.mL-1, c3= 25.0 µg.mL-1, c4= 31.3 µg.mL-1,
c5= 37.5 µg.mL-1). At λ~281 nm all spectra have zero value.
In the next step of this study the conditions of
method were validated by determining specificity,
linearity range, detection limit and quantitation limit
as well as accuracy based on the results of analysis
obtained for the drug under investigation (15). 
Specificity
To find an effect of matrix constituents on the
results of determination, comparative analysis was
carried out for standard solution containing active
components at concentrations comparable to those
of the analyzed preparation (Fig. 6). The values of
derivatives at selected wavelengths for the sample
and standard solution were within admissible errors
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of spectrophotometric method, thus one can con-
clude that the results of determination remain unaf-
fected by auxiliary constituents of the drug.
Linearity
To check the range of linearity 5 measurements
were made for each solution at concentrations from
100.0 µg.mL-1 to 300.0 µg.mL-1 and from 12.50
µg.mL-1 to 37.50 µg.mL-1 for metoprolol and
hydrochlorothiazide, respectively. The following
results were obtained by using equations of linear
regression: 
for metoprolol (D3) = ñ 0.0010 + 0.0002 . c,
r = 0.9995 
for hydrochlorotiazide (D1) = ñ 0.0002 ñ 0.0041 . c,
r = 0.9983
Detection limit and quantitation limit
The detection limit and quantitation limit were
established from analysis of solutions of decreasing
concentrations of analyzed substances. It was found
that the detection limit is 5.0 µg.mL-1 for metoprolol,
while its quantitation limit is 15.0 µg.mL-1. The values
for hydrochlorothiazide are 1.5 µg.mL-1 and 4.5
µg.mL-1, correspondingly.
Accuracy
The accuracy of the method was determined
from percentage recovery by analyzing concentra-
tions of metoprolol and hydrochlorothiazide added
to sample solution at amounts from 80% to 120% of
the declared values. The obtained results along with
statistical evaluation, including mean ( ñX), standard
Figure 5. First order derivative uv spectra for metoprolol. At λ~282 nm all spectra have zero value.
Figure 6. Uv spectra for analyzed preparation (A) and standard solution (B).




metoprolol 102.9 Sx 1.9346





hydrochlorothiazide 12.6 Sx 0.4336
[12,5 mg/ tablet] 13.0 t0,95 ±0.455
13.1 [%]RSD 3.34
13.4 
ñX ñ mean, Sx ñ standard deviation, [%]RSD ñ relative standard deviation, t0,95 ñ confidence interval
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deviation (Sx), relative standard deviation ([%]RSD)
and confidence interval (t0,95 ) are listed below: 
metoprolol [%]: 98.76, 100.41, 97.63, 98.46, 98.69, 
ñX = 98.79, Sx = 1,0112, t0,95 = ±1,2558, [%]RSD = 1,02;
hydrochlorothiazide [%]: 103.28, 98.39, 100.0, 98.41,
96.88, 
ñX= 99.39, Sx = 2.4375, t0,95 = ±3.0263, [%]RSD = 2.45.
Suitability of the developed method for deter-
mining metoprolol and hydrochlorothiazide was suc-
cessfully checked for the complex drug
MetoprololñRatiopharm comp, containing both ana-
lyzed substances (Table 1). 
CONCLUSIONS 
A quick and accurate method for determining
metoprolol and hydrochlorothiazide was developed
by using derivative spectrophotometry.
The advantage of this method is that both con-
stituents can be determined directly in a single sam-
ple without the need to be separated. 
It was also found that auxiliary drug compo-
nents had no effect on the results of determination
obtained under established conditions. 
The method gives results of high accuracy and
high recovery of 98.79% and 99.39% for metoprolol
and hydrochlorothiazide, respectively at good preci-
sion; [%]RSD does not exceed 2.5%. 
Satisfactory results were obtained also for the
drug under investigation and the obtained values do
not differ from those declared by the manufacturer.
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Table 1. Results of determination of metoprolol and hydrochlorothiazide in tablets. 
